Home
Who We Are
Vision
Team Overview
Careers
Our Businesses
Therapeutics
Exchange
Labs
Real-World Data
Platform
News & Media
Contact Us
EN
新闻、洞察、创新、亮点
GRANTS & PARTNERS
新闻与媒体
客户评价与奖项
News
Partex Accelerates Antibody Engineering for Neurodegenerative Diseases Using NVIDIA-Accelerated AI / ML Platform
继续阅读 →
News
Partex and Ark Biopharmaceutical Expand Strategic Collaboration with New Out-Licensing Agreement for ATR Inhibitor AK0658
继续阅读 →
News
Partex and Fortress Biotech Announce Strategic Collaboration to Accelerate Asset Identification and Evaluation Using Proprietary AI Platform
继续阅读 →
News
Partex Announces Strategic Collaboration with Princeton Drug Discovery Ltd for Out-Licensing of PDD-87
继续阅读 →
News
Die Arbeitsgemeinschaft Internistische Onkologie (AIO) und AMRIT entwickeln innovativen onkologischen Datenhub
继续阅读 →
News
Partex Announces Strategic Collaboration with Shanghai Ark Biopharmaceutical for Partnership and Out-Licensing of AK0707
继续阅读 →
News
Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development
继续阅读 →
News
Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation
继续阅读 →
News
Partex NV announces collaboration with Althea DRF Lifesciences to provide comprehensive end-to-end services to accelerate drug discovery and development
继续阅读 →
News
Innovative AI technology in oncology: Partex Group presents results from a pilot project
继续阅读 →
News
Partex NV Forges Collaboration with Sanofi in AI-Based Dossier Enrichment for Out-Licensing
继续阅读 →
News
Innoplexus and AIO Studien gGmbH are jointly announcing the start of a pilot project as part of the AIO data hub initiative
继续阅读 →
News
Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing
继续阅读 →
News
AI supports targeted therapy recommendations for tumor diseases – BMBF funds joint research project at University Medical Center Mainz with 2.53 million Euros
继续阅读 →
News
OncoCoin AG donates for a charity bicycle tour: Tour of Hope
继续阅读 →
News
Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry
继续阅读 →
News
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence
继续阅读 →
News
Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform
继续阅读 →
News
Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic
继续阅读 →
News
Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will
继续阅读 →
News
Der Pharma-Visionär
继续阅读 →
News
Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona
继续阅读 →
News
New app for cancer patients
继续阅读 →
News
Role of AI soars in tackling Covid-19 pandemic
继续阅读 →
News
PartexAI Announces Major Findings in Potential Combination Therapies for COVID-19
继续阅读 →
News
PartexAI wins Silver Edison Award for OntosightⓇ Explore
继续阅读 →
News
PartexAI: Big Steps to Combat the Coronavirus
继续阅读 →
News
PartexAI Opens Its Ontosight® AI Search Platform to COVID-19 Research
继续阅读 →
News
PartexAI AG announces the appointment of Christian Bigatà Joseph as Chief Financial Officer (CFO) and Dr. Katharina Schreeb as Chief Medical Officer (CMO)
继续阅读 →
News
PartexAI Consulting Services is Proud to Announce ISO/IEC 27001:2013 Certification
继续阅读 →
News
Catana Capital: New collaboration with Life Science AI pioneer Partex.AI
继续阅读 →
News
PartexAI and Wiley partner to provide AI-powered solutions over comprehensive research literature
继续阅读 →
News
PartexAI and ChemAxon partner to get more out of life science data
继续阅读 →
News
PartexAI Announces Appointment of Stratos Davlos as Chief Technology Officer (CTO) and Senior Vice President
继续阅读 →
News
Traum aller Anleger
继续阅读 →
News
PartexAI Announces Appointment of Rita Kelley as Senior Vice President and Managing Director, USA
继续阅读 →
News
PartexAI and Cures Within Reach for Cancer Tap the Power of Artificial Intelligence to Find Off-Patent Non-Cancer Drugs That Have Potential to Treat Cancer
继续阅读 →
News
AI CTP engine estimated failure for Biogen’s aducanumab
继续阅读 →
News
Predicting Drug Flops with AI
继续阅读 →
News
Google for Healthcare
继续阅读 →
News
Lessons Learned from Other Industries
继续阅读 →
News
PartexAI Launches Worldwide Academic Access Program for its Flagship Ontosight.ai
继续阅读 →
News
PartexAI AG wird Mitglied im Bundesverband für Künstliche Intelligenz (KI)
继续阅读 →
News
Künstliche Intelligenz auf dem Vormarsch
继续阅读 →
News
Google für die Pharmabranche
继续阅读 →
News
Wir wollen Daten demokratisieren
继续阅读 →
News
Ein Gründer bekämpft Krebs mit künstlicher Intelligenz
继续阅读 →
News
„Deutsche Tugenden sind bei KI und Deep-Tech ein Wettbewerbsvorteil“
继续阅读 →
News
Pioniere der nächsten digitalen Revolution
继续阅读 →
News
PartexAI WIEDER IM GARTNER HYPE CYCLE FÜR LIFE SCIENCES
继续阅读 →
News
Google für die Gesundheitsbranche
继续阅读 →
News
How can AI be leveraged for Clinical Trial Prediction?
继续阅读 →
News
PartexAI, a leading AI and Life Sciences company, raises double-digit million dollar series C round from FinLab EOS VC and others
继续阅读 →
News
PartexAI’ Clinical Trial Prediction Engine predicted Aducanumab Failure
继续阅读 →
News
An AI Firm Wants to Predicts Costly Pharma Flops
继续阅读 →
News
Finger on the Pulse: GTC Spotlights Startups Propelling AI in Healthcare
继续阅读 →
News
Pharma & Healthcare Analytics Is Going To Be The Next Big Thing In India
继续阅读 →
News
PartexAI: Real-Time Data Analytics to Empower Decision Making
继续阅读 →
News
8 Startups Ahead of the Pulse in Healthcare
继续阅读 →
News
Pharma Outlook: 12 Trends to Watch in 2019
继续阅读 →
News
Mobilize data trapped in silos with Blockchain and AI
继续阅读 →
News
Can AI help in Drug Development ?
继续阅读 →
News
The Story Of Disrupting AI-Driven Team
继续阅读 →
News
Building AI Foundation
继续阅读 →
News
PartexAI INCLUDED AGAIN IN GARTNER HYPE CYCLE FOR LIFE SCIENCES
继续阅读 →
News
How blockchain and AI can help us decipher medicine's big data
继续阅读 →
News
AI able to ‘predict impact of minor changes’ to manufacturing
继续阅读 →
News
Blockchain in Healthcare: 6 Possible Use Cases
继续阅读 →
News
5 predictions for AI in 2019
继续阅读 →
News
Five AI Healthcare Startups Bringing Us Closer to Cures
继续阅读 →
News
PartexAI Brings Blockchain to Pharma
继续阅读 →
News
Founder fights cancer with artificial intelligence
继续阅读 →
News
AI-based drug development to broaden gap between pharmaceuticals
继续阅读 →
News
Google for Pharma
继续阅读 →
News
We want to democratize data
继续阅读 →
News
How artificial intelligence impacts preventative care
继续阅读 →
News
More transparency would bolster big pharma’s image
继续阅读 →
News
PartexAI is working on solutions in response to GDPR and other data privacy restrictions
继续阅读 →
News
Why AI and blockchain are the solutions to developing orphan drug
继续阅读 →
News
Who will be the disruptor that pharma is waiting for?
继续阅读 →
News
Blockchain can take pharma collaboration and innovation to new heights
继续阅读 →
News
New Blockchain Platform from Partex.AI Will Bring Us Better, Cheaper Drugs
继续阅读 →
News
How Eliminating Data Silos Will Democratize Pharma R&D
继续阅读 →
News
Why blockchain is a dream come true for pharma researchers
继续阅读 →
News
Four steps to building an innovation culture in pharma
继续阅读 →
News
How AI and Blockchain Can Help Pharma Companies Avoid Duplicative Work
继续阅读 →
News
How The Ethereum [ETH] Blockchain Is Powering The Next Generation Of Pharma Innovation
继续阅读 →
News
CEO and Founder Gunjan Bhardwaj, PhD On Driving Innovation and Ensuring Success
继续阅读 →
News
PartexAI launches new Blockchain platform for Pharma innovation
继续阅读 →
News
3 Reasons why Partex.AI is bringing Blockchain to Pharma
继续阅读 →
News
PartexAI launches Blockchain platform to drive Pharma innovation
继续阅读 →
News
Beyond competition, Partex.AI believes in collaboration to nurture the ecosystem in a data-driven world
继续阅读 →
News
Gunjan Bhardwaj on “The American Dream”
继续阅读 →
News
When should pharma execs actually care about AI?
继续阅读 →
News
Consumer perceptions of pharma
继续阅读 →
News
How Blockchain And AI Can Help Pharma Focus On Innovation Rather Than Advertising
继续阅读 →
News
How blockchain will revolutionize clinical trials
继续阅读 →
News
Big data, AI and social media are the changing face of pharma marketing
继续阅读 →
News
How AI And Blockchain Can Revolutionize Pharmaceutical Trials
继续阅读 →
News
To unlock innovation, pharma needs to be honest about failure
继续阅读 →
News
How AI and blockchain can reduce corruption in Big Pharma
继续阅读 →
News
AI and Blockchain Platform Set to Revolutionize Drug Discovery
继续阅读 →
News
Blockchain and AI-based Platform iPlexus to Revolutionize Drug Discovery
继续阅读 →
News
German Blockchain, AI Platform to ‘Democratize’ Drug Development
继续阅读 →
News
PartexAI has been accepted to NVIDIA Inception Program
继续阅读 →
News
Is Open Data the Silver Bullet for Better Drugs?
继续阅读 →
News
New Blockchain and AI-based Platform to Revolutionize Drug Discovery
继续阅读 →
News
How Blockchain leverages the Power of Failure in Drug Development for the benefit of the patient
继续阅读 →
News
PartexAI's New North American Affiliate is Bringing AI Innovation to the US Pharma Industry
继续阅读 →
News
PartexAI Releases New Study Examining Consumer Perceptions of Pharmaceutical Companies
继续阅读 →
News
PartexAI supports the European Summer School in Logic, Language and Information
继续阅读 →
News
PartexAI Announces New North American Affiliate Helmed by Former Merck KGaA Executive
继续阅读 →
News
Innoplexus supports the WHO “Save Lives – Clean Your Hands” -Campaign 2018 with AI technology
继续阅读 →
News
Why Amazon Needs AI At The Center Of Its Healthcare Strategy Forbes Technology Council
继续阅读 →
News
Five use cases for blockchain in pharma Pharmaphorum
继续阅读 →
News
TiE Inflect 2018 Partex.AI AG as a 2018 TiE50 Finalist
继续阅读 →
News
Third Wave of Artificial intelligence promises the first AI Summit organised by Partex.AI and Frankfurt School of Finance & Management
继续阅读 →
News
Drug Prices Are Too Expensive: Here's How Technology Can Fix That Forbes Technology Council
继续阅读 →
News
Can blockchain solve pharma’s counterfeit drug problem? Pharmaphorum
继续阅读 →
News
How Partex.AI uses smart and on-edge technology to help its pharma clients find relevant answers hidden in unstructured data
继续阅读 →
News
Leveraging AI and Blockchain to Transform Healthcare
继续阅读 →
News
How Blockchain Can Improve the Pharma Manufacturing Supply Chain Pharmaphorum
继续阅读 →
News
Why pharma companies need to upgrade their intelligence Pharmaphorum
继续阅读 →
News
How artificial intelligence powers healthcare innovation Digital Commerce 360
继续阅读 →
News
Solving the Big Data problem in pharma innovation Pharmaphorum
继续阅读 →
News
Using AI & Machine Learning, Indo-German company Partex.AI is helping reduce the time it takes for medicines to reach patients
继续阅读 →
News
How AI, blockchain, and big data can reduce drug development costs Pharmaphorum
继续阅读 →
News
How AI Is Transforming The Future Of Healthcare
继续阅读 →
News
PartexAI strengthens its global leadership team with accomplished leaders- appoints Silke Otte as Chief Marketing Officer and Graeme Mcfarlane as the Chief Commercial Officer
继续阅读 →
News
Gaining Momentum: Ex – President, Merck KGaA (Latin America), Lawrence Ganti joins Partex.AI as CEO, Americas
继续阅读 →
News
PartexAI @ Machine Intelligence Summit, Berlin 2017
继续阅读 →
News
Accelerating innovation in Pharma with Artificial Intelligence & Big Data
继续阅读 →
News
PartexAI Proudly Announces the Launch of its Product iPlexus, at Bio-IT World, 2017
继续阅读 →
News
PartexAI featured on Inc.
继续阅读 →
News
PartexAI talks about Cybersecurity with Entrepreneur.com
继续阅读 →
News
PartexAI at Bio-IT World
继续阅读 →
News
PartexAI Featured in DataQuest
继续阅读 →
News
PartexAI signs MoU to provide academic license for its iPlexus platform to Regional Cancer Centre, Gwalior, India
继续阅读 →
News
German VC firm invests in Data as a Service startup Partex.AI
继续阅读 →
我们不仅发现药物
我们管理它们的未来
与我们联系,探索许可、合作伙伴关系,或AI如何重塑您的药物管线
联系我们